• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类固醇对人培养乳腺癌细胞中芳香化酶活性的调节作用。

Steroid modulation of aromatase activity in human cultured breast carcinoma cells.

作者信息

Perel E, Daniilescu D, Kharlip L, Blackstein M, Killinger D W

机构信息

Department of Medicine, Wellesley Hospital, University of Toronto, Ontario, Canada.

出版信息

J Steroid Biochem. 1988 Apr;29(4):393-9. doi: 10.1016/0022-4731(88)90248-8.

DOI:10.1016/0022-4731(88)90248-8
PMID:3374128
Abstract

Cortisol and steroids with progestational or androgenic activity were studied to determine the effects of these steroids on the conversion of androstenedione (A) to estrone (E1) in human cultured breast carcinoma cells. Cortisol (10(-6) M) stimulated aromatase activity in two estrogen unresponsive cell lines (MD, DM) and in an estrogen responsive cell line (MCF7) with the maximum stimulation occurring during confluence. Cortisol inhibited the replication of MCF7 cells but not MD and DM. Dihydrotestosterone, androsterone and 5 alpha-androstanedione (10(-6) M) inhibited the conversion of A to E1 by greater than 90% under basal and cortisol stimulated conditions. Progesterone (10(-6) M) had no effect on aromatase activity while the progestational agent R5020 (10(-6) M) produced a 30% inhibition. The anabolic steroids 19-nortestosterone and 19-norandrostenedione which also have progestational activity inhibited the conversion of A to E1 in a dose dependent manner with 90% inhibition at 10(-6) M. Danazol (10(-6) M) a drug with both androgenic and progestational activity inhibited E1 formation by 30%. Under the same conditions, the known inhibitor of aromatase, 4-hydroxyandrostenedione (10(-6) M) decreased E1 formation by more than 90% and aminoglutethimide (10(-6) M) caused only 25% inhibition. These studies demonstrate that endogenous and exogenous steroids may have significant effects in modulating the local formation of estrogens from androgen precursors in cultured breast carcinoma cells. This effect on estrogen formation may be a factor in the biological response of breast tissue.

摘要

研究了具有孕激素或雄激素活性的皮质醇和类固醇,以确定这些类固醇对人培养乳腺癌细胞中雄烯二酮(A)转化为雌酮(E1)的影响。皮质醇(10^(-6)M)刺激了两种雌激素无反应细胞系(MD、DM)和一种雌激素反应细胞系(MCF7)中的芳香化酶活性,在汇合时出现最大刺激。皮质醇抑制了MCF7细胞的复制,但不抑制MD和DM细胞的复制。双氢睾酮、雄酮和5α-雄烷二酮(10^(-6)M)在基础和皮质醇刺激条件下,抑制A转化为E1的幅度大于90%。孕酮(10^(-6)M)对芳香化酶活性无影响,而孕激素R5020(10^(-6)M)产生了30%的抑制作用。同样具有孕激素活性的合成代谢类固醇19-去甲睾酮和19-去甲雄烯二酮以剂量依赖方式抑制A转化为E1,在10^(-6)M时抑制率为90%。具有雄激素和孕激素活性的药物达那唑(10^(-6)M)抑制E1形成30%。在相同条件下,已知的芳香化酶抑制剂4-羟基雄烯二酮(10^(-6)M)使E1形成减少超过90%,而氨鲁米特(10^(-6)M)仅引起25%的抑制。这些研究表明,内源性和外源性类固醇可能在调节培养的乳腺癌细胞中雄激素前体向雌激素的局部形成方面具有显著作用。这种对雌激素形成的影响可能是乳腺组织生物学反应的一个因素。

相似文献

1
Steroid modulation of aromatase activity in human cultured breast carcinoma cells.类固醇对人培养乳腺癌细胞中芳香化酶活性的调节作用。
J Steroid Biochem. 1988 Apr;29(4):393-9. doi: 10.1016/0022-4731(88)90248-8.
2
Aromatase activity in the breast and other peripheral tissues and its therapeutic regulation.乳腺及其他外周组织中的芳香化酶活性及其治疗调控。
Steroids. 1987 Oct-Dec;50(4-6):523-36. doi: 10.1016/0039-128x(87)90036-5.
3
The relationship between growth and androstenedione metabolism in four cell lines of human breast carcinoma cells in culture.培养的四种人乳腺癌细胞系中生长与雄烯二酮代谢之间的关系。
Mol Cell Endocrinol. 1985 Jul;41(2-3):197-203. doi: 10.1016/0303-7207(85)90023-1.
4
The intracellular control of aromatase activity by 5 alpha-reduced androgens in human breast carcinoma cells in culture.
J Clin Endocrinol Metab. 1984 Mar;58(3):467-72. doi: 10.1210/jcem-58-3-467.
5
Steroid metabolism in the hormone dependent MCF-7 human breast carcinoma cell line and its two hormone resistant subpopulations MCF-7/LCC1 and MCF-7/LCC2.激素依赖性人MCF-7乳腺癌细胞系及其两个激素抗性亚群MCF-7/LCC1和MCF-7/LCC2中的类固醇代谢
J Steroid Biochem Mol Biol. 1997 Nov-Dec;63(4-6):275-81. doi: 10.1016/s0960-0760(97)00127-1.
6
Aromatase in human breast carcinoma.人类乳腺癌中的芳香化酶
Cancer Res. 1982 Aug;42(8 Suppl):3369s-3372s.
7
Biological significance of aromatase activity in human breast tumors.人乳腺肿瘤中芳香化酶活性的生物学意义。
J Clin Endocrinol Metab. 1983 Dec;57(6):1125-8. doi: 10.1210/jcem-57-6-1125.
8
Comparison of the effect of cortisol on aromatase activity and androgen metabolism in two human fibroblast cell lines derived from the same individual.皮质醇对源自同一个体的两种人成纤维细胞系中芳香化酶活性和雄激素代谢影响的比较。
J Steroid Biochem. 1990 May;35(6):679-87. doi: 10.1016/0022-4731(90)90308-f.
9
Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.人乳腺癌中雌激素生成的酶促调控:芳香化酶与硫酸酯酶途径的相对重要性。
Ann N Y Acad Sci. 1986;464:126-37. doi: 10.1111/j.1749-6632.1986.tb16000.x.
10
The role of aromatase in breast tumors.芳香化酶在乳腺肿瘤中的作用。
Breast Cancer Res Treat. 1994;30(1):7-17. doi: 10.1007/BF00682737.

引用本文的文献

1
Benign Metastasizing Leiomyomatosis to the Skin and Lungs, Intravenous Leiomyomatosis, and Leiomyomatosis Peritonealis Disseminata: A Series of Five Cases.良性转移性平滑肌瘤病至皮肤和肺部、静脉内平滑肌瘤病和播散性腹膜平滑肌瘤病:五例系列病例。
Oncologist. 2022 Feb 3;27(1):e89-e98. doi: 10.1093/oncolo/oyab019.
2
Novel hormone treatment of benign metastasizing leiomyoma: an analysis of five cases and literature review.新型激素治疗良性转移性平滑肌瘤:五例病例分析及文献复习。
Fertil Steril. 2013 Jun;99(7):2017-24. doi: 10.1016/j.fertnstert.2013.01.147. Epub 2013 Mar 5.
3
Effects of prenatal stress on the activity of an enzyme involved in neurosteroid synthesis during the "critical period" of sexual differentiation of the brain in male rats.
Neurosci Behav Physiol. 2005 Nov;35(9):931-5. doi: 10.1007/s11055-005-0148-4.
4
Formestane. A review of its pharmacological properties and clinical efficacy in the treatment of postmenopausal breast cancer.福美司坦。其治疗绝经后乳腺癌的药理特性及临床疗效综述。
Drugs Aging. 1996 Oct;9(4):292-306. doi: 10.2165/00002512-199609040-00006.
5
Formestane. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of breast cancer and prostatic cancer.福美司坦。对其药效学、药代动力学特性以及在乳腺癌和前列腺癌治疗中的潜在应用的综述。
Drugs. 1993 Jan;45(1):66-84. doi: 10.2165/00003495-199345010-00007.
6
Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020).雌酮和雌二醇在激素依赖性和激素非依赖性人乳腺癌细胞中的转化。抗雌激素ICI 164,384、达那唑和普美孕酮(R-5020)的作用。
Breast Cancer Res Treat. 1995 May;34(2):139-46. doi: 10.1007/BF00665786.